Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Lancet (London, England)
|
April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
K Papp, R Bissonnette, L Rosoph, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2016
Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council
J J Wu, C W Lynde, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
A B Kimball, K A Papp, Y Wasfi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 2, 2014
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)
K A Papp, K Barber, R Bissonnette, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 23, 2015
Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
K A Papp, K Barber, R Bissonnette, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
February 16, 2000
Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone
J Shapiro, J P Sundberg, R Bissonnette, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 15, 2018
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)
R Bissonnette, T Luger, D Thaçi, et al.
The British Journal of Dermatology
|
July 17, 2016
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
R Bissonnette, K A Papp, Y Poulin, et al.
Analytica Chimica Acta
|
October 10, 2025
Identification of micro-/nanoplastics in human placental blood using comprehensive multidimensional pyrolysis - gas chromatography x ion mobility mass spectrometry
Justine R Bissonnette, Nikita E Harvey, Mikela L Rowsell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 1997
Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity
Y Kawakami, T Miura, R Bissonnette, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Lancet (London, England)
|
April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
K Papp, R Bissonnette, L Rosoph, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2016
Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council
J J Wu, C W Lynde, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
A B Kimball, K A Papp, Y Wasfi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 2, 2014
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)
K A Papp, K Barber, R Bissonnette, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 23, 2015
Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
K A Papp, K Barber, R Bissonnette, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
February 16, 2000
Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone
J Shapiro, J P Sundberg, R Bissonnette, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 15, 2018
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)
R Bissonnette, T Luger, D Thaçi, et al.
The British Journal of Dermatology
|
July 17, 2016
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
R Bissonnette, K A Papp, Y Poulin, et al.
Analytica Chimica Acta
|
October 10, 2025
Identification of micro-/nanoplastics in human placental blood using comprehensive multidimensional pyrolysis - gas chromatography x ion mobility mass spectrometry
Justine R Bissonnette, Nikita E Harvey, Mikela L Rowsell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 1997
Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity
Y Kawakami, T Miura, R Bissonnette, et al.
Page
of 11